NCT04488315View on ClinicalTrials.gov

Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-craniotomy Pain

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

September 26, 2023

Study Completion Date

December 25, 2023

Conditions

Pain, Postoperative

Interventions

DRUG

Dexamethasone lipid microsphere plus ropivacaine

Local scalp infiltration solution will consist of 30ml miscible liquids containing 8 mg dexamethasone lipid microsphere, 150mg ropivacaine and normal saline.

DRUG

Ropivacaine alone

Local scalp infiltration solution will consist of 30ml miscible liquids containing 150mg ropivacaine and normal saline

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors

lead

Beijing Tiantan Hospital

OTHER

NCT04488315 - Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-craniotomy Pain | Biotech Hunter | Biotech Hunter